Tianming Li
Shanghai, 200092, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
Retraction Notice to: SET1A Cooperates With CUDR to Promote Liver Cancer Growth and Hepatocyte-like Stem Cell Malignant Transformation Epigenetically.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: April 06, 2023
CircMEG3 inhibits telomerase activity by reducing Cbf5 in human liver cancer stem cells.
Journal: Molecular therapy. Nucleic acids
Published: July 30, 2020
miR-155 Accelerates the Growth of Human Liver Cancer Cells by Activating CDK2 via Targeting H3F3A.
Journal: Molecular therapy oncolytics
Published: March 22, 2020
Long noncoding RNA HULC accelerates the growth of human liver cancer stem cells by upregulating CyclinD1 through miR675-PKM2 pathway via autophagy.
Journal: Stem cell research & therapy
Published: June 20, 2019
miR24-2 Promotes Malignant Progression of Human Liver Cancer Stem Cells by Enhancing Tyrosine Kinase Src Epigenetically.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: May 10, 2019
miR24-2 accelerates progression of liver cancer cells by activating Pim1 through tri-methylation of Histone H3 on the ninth lysine.
Journal: Journal of cellular and molecular medicine
Published: February 20, 2019
miR675 Accelerates Malignant Transformation of Mesenchymal Stem Cells by Blocking DNA Mismatch Repair.
Journal: Molecular therapy. Nucleic acids
Published: April 14, 2018
Long noncoding RNA HULC accelerates liver cancer by inhibiting PTEN via autophagy cooperation to miR15a.
Journal: Molecular cancer
Published: January 21, 2018
miR372 Promotes Progression of Liver Cancer Cells by Upregulating erbB-2 through Enhancement of YB-1.
Journal: Molecular therapy. Nucleic acids
Published: November 11, 2017
Inflammatory-Related P62 Triggers Malignant Transformation of Mesenchymal Stem Cells through the Cascade of CUDR-CTCF-IGFII-RAS Signaling.
Journal: Molecular therapy. Nucleic acids
Published: October 31, 2017
Long noncoding RNA MEG3 suppresses liver cancer cells growth through inhibiting β-catenin by activating PKM2 and inactivating PTEN.
Journal: Cell death & disease
Published: August 11, 2017
Last Updated: 09/26/2026